Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy

Abstract

In patients with systemic sclerosis (SSc) treatment-related mortality after autologous stem cell transplantation (ASCT) appears to be increased as compared to patients with hematological malignancies. In our phase I/II study on ASCT in autoimmune diseases a patient with SSc died on day 2 after ASCT. Here we report the results of the autopsy which revealed advanced pulmonary and cardiac fibrosis as the most probable cause of death. In spite of detailed technical examination before enrollment, the cardiopulmonary function tests did not reflect the advanced stage of the disease. We conclude that in selected patients with SSc, biopsies should be performed to reduce mortality after ASCT. Bone Marrow Transplantation (2001) 27, 657–658.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Tyndall A, Gratwohl A . Immune ablation and stem-cell therapy in autoimmune disease. Clinical experience Arthr Res 2000 2: 276–280

    Article  CAS  Google Scholar 

  2. Rosen O, Thiel A, Massenkeil G et al. Autologous stem cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells Arthr Res 2000 2: 327–336

    Article  CAS  Google Scholar 

  3. Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) Br J Rheumatol 1997 36: 390–392

    Article  CAS  Google Scholar 

  4. Appelbaum F, Strauchen JA, Graw RG Jr et al. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity Lancet 1976 1: 58–62

    Article  CAS  Google Scholar 

  5. Buja LM, Ferrans VJ, Graw RG Jr . Cardiac pathologic findings in patients treated with bone marrow transplantation Hum Pathol 1976 7: 17–45

    Article  CAS  Google Scholar 

  6. Kumar S, Gupta RK, Bhake AS, Samal N . Cardiotoxic effects of high doses of cyclophosphamide in albino rats Arch Pharmaco Ther 1992 319: 58–65

    CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the nurses and the staff of the BMT Unit of the University Hospital Charité for the excellent care provided to our patients.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosen, O., Massenkeil, G., Hiepe, F. et al. Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant 27, 657–658 (2001). https://doi.org/10.1038/sj.bmt.1702829

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702829

Keywords

This article is cited by

Search

Quick links